UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Maybe myopathic EMG but not myopathy

Clinical neurophysiology, 2021-09, Vol.132 (9), p.2323-2323

Cornblath, David R.

2021

Link zum Volltext

Verfügbarkeit prüfen

Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Lancet neurology, 2019-08, Vol.18 (8), p.784-794

2019

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barré syndrome: An update

Journal of clinical neuroscience, 2009-06, Vol.16 (6), p.733-741

2009

Link zum Volltext

Verfügbarkeit prüfen

A Dominant Mutation in FBXO38 Causes Distal Spinal Muscular Atrophy with Calf Predominance

American journal of human genetics, 2013-11, Vol.93 (5), p.976-983

2013

Link zum Volltext

Verfügbarkeit prüfen

DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4)

American journal of human genetics, 2004-06, Vol.74 (6), p.1128-1135

2004

Link zum Volltext

Verfügbarkeit prüfen

Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery

Parkinsonism & related disorders, 2013-05, Vol.19 (5), p.501-507

2013

Link zum Volltext

Verfügbarkeit prüfen

The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials

Clinical therapeutics, 2012-05, Vol.34 (5), p.1056-1069

2012

Link zum Volltext

Verfügbarkeit prüfen

Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment

Journal of the neurological sciences, 2013-07, Vol.330 (1), p.2-3

2013

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

Trials, 2016-07, Vol.17 (1), p.345-345, Article 345

2016

Link zum Volltext

Verfügbarkeit prüfen

Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria

Vaccine, 2011-12, Vol.29 (52), p.9697-9701

2011

Link zum Volltext

Verfügbarkeit prüfen

Linkage of the Gene for an Autosomal Dominant Form of Juvenile Amyotrophic Lateral Sclerosis to Chromosome 9q34

American journal of human genetics, 1998-03, Vol.62 (3), p.633-640

1998

Link zum Volltext

Verfügbarkeit prüfen

Congenital End-Plate Acetylcholinesterase Deficiency Caused by a Nonsense Mutation and an A→G Splice-Donor–Site Mutation at Position +3 of the Collagenlike-Tail–Subunit Gene ( COLQ): How Does G at Position +3 Result in Aberrant Splicing?

American journal of human genetics, 1999-09, Vol.65 (3), p.635-644

1999

Link zum Volltext

Verfügbarkeit prüfen

IgPro20, the Polyneuropathy and Treatment with Hizentra

Immunotherapy, 2018-05

2018

Link zum Volltext

Verfügbarkeit prüfen

18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment

Clinical neurophysiology, 2020-03, Vol.131 (3), p.e8-e8

2020

Link zum Volltext

Verfügbarkeit prüfen

19. Pharmacokinetic modelling and simulation of flexible dosing regimens of subcutaneous immunoglobulin (IgPro20) in CIDP patients

Clinical neurophysiology, 2020-03, Vol.131 (3), p.e8-e9

2020

Link zum Volltext

Verfügbarkeit prüfen

17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study

Clinical neurophysiology, 2020-03, Vol.131 (3), p.e7-e8

2020

Link zum Volltext

Verfügbarkeit prüfen

21. Exposure-response of serum IgG levels and INCAT scores in CIDP patients receiving subcutaneous immunoglobulin (IgPro20)

Clinical neurophysiology, 2020-03, Vol.131 (3), p.e9-e10

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuropathy in Grout Workers

Scandinavian Journal of Work, Environment ＆ Health, 2004-06, Vol.30 (3), p.253-254

2004

Link zum Volltext

Verfügbarkeit prüfen

Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel

Nature genetics, 1992-10, Vol.2 (2), p.148-152

1992

Link zum Volltext

Verfügbarkeit prüfen

Demylinating Peripheral Neuropathy and Lymphoplasmacytic Lymphoma

Blood, 2010-11, Vol.116 (21), p.5090-5090

2010

Link zum Volltext

Verfügbarkeit prüfen

Intravenous versus subcutaneous immunoglobulin – Authors' reply

Lancet neurology, 2018-05, Vol.17 (5), p.393-394

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maybe myopathic EMG but not myopathy

Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Guillain-Barré syndrome: An update

A Dominant Mutation in FBXO38 Causes Distal Spinal Muscular Atrophy with Calf Predominance

DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4)

Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery

The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials

Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria

Linkage of the Gene for an Autosomal Dominant Form of Juvenile Amyotrophic Lateral Sclerosis to Chromosome 9q34

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

Congenital End-Plate Acetylcholinesterase Deficiency Caused by a Nonsense Mutation and an A→G Splice-Donor–Site Mutation at Position +3 of the Collagenlike-Tail–Subunit Gene ( COLQ): How Does G at Position +3 Result in Aberrant Splicing?

IgPro20, the Polyneuropathy and Treatment with Hizentra

18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment

19. Pharmacokinetic modelling and simulation of flexible dosing regimens of subcutaneous immunoglobulin (IgPro20) in CIDP patients

17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study

21. Exposure-response of serum IgG levels and INCAT scores in CIDP patients receiving subcutaneous immunoglobulin (IgPro20)

Neuropathy in Grout Workers

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data

Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel

231st ENMC International Workshop:: International Standard for CIDP Registry and Biobank, Naarden, The Netherlands, 12–14 May 2017

230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017

Demylinating Peripheral Neuropathy and Lymphoplasmacytic Lymphoma

Intravenous versus subcutaneous immunoglobulin – Authors' reply

Aktive Filter

Suchergebnisse filtern